NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

Lykiri,

Thanks for sharing this update. Looks like the Germans expected top line data to be compiled after the last patient got their last expected dose in February this year (120 weeks from early November 2015). So what we have is blended/blinded data submitted in November to a journal, Spring refresh data expected by June and perhaps 3 year OS (if allowed) given to the Europeans in the Summer (from diagnosis) or held for the Fall (from enrollment). The wild cards appear to be the October 2017 meeting in Canada, RMAT, Right To Try and any desire to reach the completed 3 year data set from 1st treatment which happens in November. Best wishes.